Santero Therapeutics
Charleroi · Founded 2021
About Santero Therapeutics
Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2023)
- Website: http://www.santero.be/
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/santero-therapeutics-80008 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.